HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$1.20
Day range
$1.14 - $1.21
Year range
$1.00 - $2.68
Market cap
220.03M USD
Avg Volume
1.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 40.59M | -0.47% |
Operating expense | 38.11M | 64.27% |
Net income | -2.95M | -180.64% |
Net profit margin | -7.28 | -181.07% |
Earnings per share | -0.02 | -200.00% |
EBITDA | 575.00K | -87.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 46.63M | -21.34% |
Total assets | 255.88M | 9.75% |
Total liabilities | 241.54M | -9.47% |
Total equity | 14.33M | — |
Shares outstanding | 188.31M | — |
Price to book | 17.14 | — |
Return on assets | 0.04% | — |
Return on capital | 0.06% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.95M | -180.64% |
Cash from operations | -9.18M | 22.04% |
Cash from investing | -5.46M | -147.78% |
Cash from financing | 219.00K | -48.23% |
Net change in cash | -14.42M | -23,740.98% |
Free cash flow | -20.06M | -32.69% |
About
Founded
1983
Headquarters
Website
Employees
128
